NCT02653677

Brief Summary

The purposes of the present study are to determine the glycemic and insulinemic responses, the satiety rate and the postprandial plasma concentrations of free fatty acids, triglycerides and satiety hormones after the ingestion of four types of breads: handcrafted bread made with wheat organic flour; handcrafted bread with wheat flour of large-scale retail distribution; handcrafted bread with organic einkorn flour and a commercial wheat bread.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 12, 2016

Completed
Last Updated

January 12, 2016

Status Verified

January 1, 2016

Enrollment Period

5 months

First QC Date

January 6, 2016

Last Update Submit

January 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glucose-under-the curve (AUC) after ingestion of 4 types of bread

    Glycemic AUC is defined as the blood glucose increment over 2 hours in response to the consumption of the amount of bread providing 50 g of available carbohydrates

    0 to 120 minutes after the ingestion of each bread

Secondary Outcomes (1)

  • Insulin-under-the curve (AUC) after ingestion of 4 types of bread

    0 to 120 minutes after the ingestion of each bread

Other Outcomes (2)

  • Free fatty acid (FFA) AUC after the ingestion of 4 types of bread

    0 to 120 minutes after the ingestion of each bread

  • Ghrelin responses after the ingestion of 4 types of bread

    0 to 120 minutes after the ingestion of each bread

Study Arms (4)

commercial bread, wheat flour

ACTIVE COMPARATOR

Intake of the specific kind of bread

Other: intake of the specific kind of bread

wheat, organic flour

EXPERIMENTAL

Intake of the specific kind of bread

Other: intake of the specific kind of bread

wheat, supermarket flour

EXPERIMENTAL

Intake of the specific kind of bread

Other: intake of the specific kind of bread

einkorn, organic flour

EXPERIMENTAL

intake of the specific kind of bread

Other: intake of the specific kind of bread

Interventions

To determine the glycemic and insulinemic responses (area-under the curve, AUCs), the satiety rate and the AUCs of free fatty acids (FFA), triglycerides and ghrelin after the ingestion of four types of breads, each containing 50g of available carbohydrates

commercial bread, wheat floureinkorn, organic flourwheat, organic flourwheat, supermarket flour

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • body mass index (BMI) between 18 and 25 kg/m2
  • healthy
  • Accept to participate in the study

You may not qualify if:

  • smokers
  • subjects suffering from any diseases
  • drug therapy
  • dietary supplementation
  • patients unable to give informed consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HyperglycemiaInsulin Resistance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHyperinsulinism

Study Officials

  • Simona Bo, MD

    University of Turin, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 6, 2016

First Posted

January 12, 2016

Study Start

February 1, 2015

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

January 12, 2016

Record last verified: 2016-01